Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07634393 · ClinicalTrials.gov registry record · Phase 4
Intravenous Metoclopramide Versus Intravenous Acetaminophen for Acute Concussion Treatment
A Phase 4 study, sponsored by Montefiore Medical Center.
- Not yet
- Registry status
- Phase 4
- Development phase
- 200
- Enrollment target
NCT07634393 is a Phase 4 study that has not yet begun recruiting, run by Montefiore Medical Center. The registered enrollment target is 200 participants.
The verdict
NCT07634393, a Phase 4 study, has not yet begun recruiting, sponsored by Montefiore Medical Center.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 200 participants
- Enrollment target
Study Summary
The IMPACT study is a randomized, double-blind clinical trial evaluating two commonly used intravenous medications - metoclopramide and acetaminophen - for treating acute post-concussion symptoms in emergency department patients after mild head injury. The study aims to determine which treatment more effectively improves symptoms such as headache, dizziness, nausea, concentration difficulties, and emotional changes within the first week after injury. Participants will be enrolled across two Montefiore emergency departments and followed using a validated post-concussion symptom questionnaire. Findings from this study may help improve evidence-based treatment strategies for patients experiencing concussion-related symptoms after head trauma.
Interventions
- DRUG Acetaminophen
- DRUG Metoclopramide 10mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2026-08-01 |
| Est. Completion | 2028-08-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07634393
The ClinicalTrials.gov registry entry for NCT07634393 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acetaminophen is the first listed.
NCT07634393 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07634393 about?
NCT07634393 is a clinical study titled "Intravenous Metoclopramide Versus Intravenous Acetaminophen for Acute Concussion Treatment". The IMPACT study is a randomized, double-blind clinical trial evaluating two commonly used intravenous medications - metoclopramide and acetaminophen - for treating acute post-concussion symptoms in emergency department patients after mild head injury. The study aims to determine which treatment mor...
What is the current status of trial NCT07634393?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2026-08-01. Estimated completion is 2028-08-04.
What interventions are being tested in trial NCT07634393?
The interventions under investigation include: Acetaminophen (DRUG), Metoclopramide 10mg (DRUG).
Who is sponsoring clinical trial NCT07634393?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.